FendousBio.ai develops focused healthcare analytics and AI-assisted drug discovery solutions. Every product begins with a defined research question and is shaped around traceability, responsible data use, and qualified human review.
Our programmes address different challenges while sharing the same commitment to evidence, transparency, and responsible development.
A mobile health-tech programme exploring early-stage health monitoring, including research into blood-group detection and glucose-level prediction. The goal is careful signal interpretation—not autonomous clinical decision-making.
An AI-assisted research environment designed to organize biological knowledge, examine candidate pathways, and help discovery teams connect evidence for expert-led investigation.
We build from a defined question to a controlled, reviewable system—with evaluation present throughout the lifecycle.
Clarify intended use, users, measurable outcomes, limitations, and decisions that must remain human.
Select governed data and scientific knowledge appropriate to the question and document provenance.
Assess performance, uncertainty, bias, explainability, safety, and realistic failure modes.
Use controlled feedback, monitoring, and documented review to guide subsequent development.
Human oversight is a system requirement.
Outputs support qualified professionals and research teams—not replace accountable judgement.
Health and life-science AI requires more than model performance. It requires clear boundaries, careful data stewardship, honest communication of limitations, and meaningful oversight.
A useful result is one that can be understood, challenged, and evaluated in its intended context.
Each system is developed for a defined context, audience, and boundary of use.
Data minimization, access controls, provenance, and privacy are considered from the beginning.
Performance claims must be linked to documented methods, suitable data, and known limitations.
Governance and validation should scale with the impact and regulatory context of the intended use.
FendousBio.ai products are in development. They are not currently medical devices and do not provide medical advice, autonomous diagnosis, treatment recommendations, or independent drug-development decisions.
We welcome conversations with healthcare professionals, researchers, life-science teams, technical collaborators, and responsible innovation partners.